Used as a key intermediate in the synthesis of antibody-drug conjugates (ADCs), enabling targeted delivery of cytotoxic agents to cancer cells. Its bifunctional structure allows stable linkage between monoclonal antibodies and potent drugs through a cleavable linker. Commonly employed in pharmaceutical development for oncology therapeutics due to its reliable conjugation chemistry and controlled release properties. Also utilized in bioconjugation research for labeling and detection applications.